Jeffrey W. Jacobs
Direttore Tecnico/Scientifico/R&S presso FULCRUM THERAPEUTICS, INC.
Posizioni attive di Jeffrey W. Jacobs
Società | Posizione | Inizio | Fine |
---|---|---|---|
FULCRUM THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2022 | - |
Storia della carriera di Jeffrey W. Jacobs
Precedenti posizioni note di Jeffrey W. Jacobs
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARDELYX, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 | 01/11/2021 |
Corporate Officer/Principal | 01/06/2008 | 01/01/2011 | |
VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2000 | 01/06/2008 |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | - | - |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Corporate Officer/Principal | - | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - | - |
AFFYMAX, INC. | Corporate Officer/Principal | - | - |
Formazione di Jeffrey W. Jacobs
Gonzaga University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Posizioni
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
ARDELYX, INC. | Health Technology |
AFFYMAX, INC. | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Commercial Services |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey W. Jacobs
- Esperienza